Tyme Technologies : Annual Report (Form 10-K)
Tyme-10k_20220331.htm Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | May 25, 2022
Source: marketscreener.com
📰 Jonathan Eckard News
Jonathan Eckard News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jonathan Eckard. Real-time updates on events, politics, business and more.
TYME Technologies, Inc. to Present at H.C. Wainwright Bioconnect Virtual Conference
BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that Richie Cunningham, Chief Executive Officer, and Jonathan Eckard, Chief Business Officer, will present at the H...
Lisam Wilson Richie Cunningham Hc Wainwright Bioconnect Jonathan Eckard Exchange Commission Technologies Inc
Source: pharmiweb.com
TYME Technologies, Inc. to Present at Jefferies London Healthcare Conference
TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), today announced that Richie Cunningham, Chief Executive
Lisam Wilson Richie Cunningham Jonathan Eckard Exchange Commission Tyme Technologies Inc Site Communications
Source: finanznachrichten.de